Drug Profile
HCT 2035
Alternative Names: Ketoprofen-NO; Nitroketoprofen; Nitroxy-butyl-ester ketoprofenLatest Information Update: 29 Sep 2003
Price :
$50
*
At a glance
- Originator NicOx
- Class Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 29 Sep 2003 HCT 2035 is no longer licensed to AstraZeneca
- 29 Sep 2003 Discontinued - Preclinical for Rheumatic disorders (PO)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed